CRBU vs DVA · rev $3.9M vs P/E 14, rev $6.97B
Caribou Biosciences Inc (CRBU) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
CRBU currently screens at market cap $190.4M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the CRBU and DVA stock pages for the full models.
Not investment advice.